Change of critical COVID-19 disease in time
Yazarlar (4)
Doç. Dr. Ufuk DEMİR Kastamonu Üniversitesi, Türkiye
Doç. Dr. Veysel Garani SOYLU Kastamonu Üniversitesi, Türkiye
Doç. Dr. Öztürk TAŞKIN Kastamonu Üniversitesi, Türkiye
Doç. Dr. Ayşe Yılmaz Kastamonu Üniversitesi, Türkiye
Makale Türü Açık Erişim Özgün Makale (Uluslararası alan indekslerindeki dergilerde yayınlanan tam makale)
Dergi Adı Kastamonu Medical Journal
Dergi ISSN 2757-9336
Dergi Tarandığı Indeksler Index Copernicus, DRJI
Makale Dili İngilizce Basım Tarihi 06-2022
Cilt / Sayı / Sayfa 2 / 2 / 35–38 DOI 10.51271/KMJ-0037
Makale Linki http://dx.doi.org/10.51271/kmj-0037
UAK Araştırma Alanları
Anesteziyoloji ve Reanimasyon
Özet
Background: COVID-19 disease, which has taken over the world for more than a year, is unfortunately not yet understood and a definitive treatment has not been found. The aim of this study is to investigate the changes in clinical and laboratory tests of critical COVID-19 patients followed in the intensive care unit between March/2020 and December/2020 and to evaluate the factors that cause these changes with literature information.Material and Method: In the study, during the beginning of the pandemic and its progress; 50 COVID-19 patients treated in the intensive care unit between March-April-May/2020 were defined as group 1, and 50 COVID-19 patients treated in the intensive care unit between October-November-December/2020 were defined as group 2. Clinical, laboratory and intensive care processes of the patients in the groups were analyzed retrospectively and compared. Results: Demographic data were similar between groups. Group 2 patients had higher 28-day mortality, and this result was statistically significant (p= 0.006). Transfer rates of group 1 patients to the service after intensive care were found to be statistically higher (p= 0.029).Conclusions: 28-day mortality was found to be different between similar patient groups who were admitted to intensive care during different periods of the pandemic. The reasons for this may be: changes in pathogenicity as a result of viral mutations, different immune responses of hosts to viral infection, intensive care experience of healthcare professionals.
Anahtar Kelimeler
BM Sürdürülebilir Kalkınma Amaçları
Atıf Sayıları
Google Scholar 1
Change of critical COVID-19 disease in time

Paylaş